UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with a revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's, and Crohn's diseases. Read More
PNN Howrah (West Bengal) [India], July 6: Iris Clothings Limited (IRISDOREME), a readymade garment company engaged in designing, manufacturing, ... ...